SEC EDGAR filings, ownership reports, and insider transactions for Frazier Life Sciences VIII, L.P..
Recent SEC filings for Frazier Life Sciences VIII, L.P. including SCHEDULE 13D/A, SC 13D/A, 4 and more.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| SCHEDULE 13D/A | Open SCHEDULE 13D/A document | View SEC filing for SCHEDULE 13D/A | 20 Aug 2025 | |||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 21 May 2024 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 29 Apr 2024 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 06 Mar 2024 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A NO. 5 | 22 Nov 2023 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 26 Oct 2023 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 26 Oct 2023 | 24 Oct 2023 | 001-39186 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 09 Aug 2022 | 05 Aug 2022 | 001-39186 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 09 Aug 2022 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 15 Feb 2022 | 11 Feb 2022 | 001-37449 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A NO. 4 | 15 Feb 2022 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 28 Jan 2022 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 21 Sep 2021 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 21 Sep 2021 | 17 Sep 2021 | 001-37449 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 May 2021 | 10 May 2021 | 001-39186 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | AMENDMENT NO. 3 TO SCHEDULE 13D | 12 May 2021 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | AMENDMENT NO. 3 TO SCHEDULE 13D | 04 May 2021 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | AMENDMENT NO. 2 TO SCHEDULE 13D | 09 Feb 2021 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 04 Feb 2021 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | AMENDMENT NO. 1 TO SCHEDULE 13D | 06 Oct 2020 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | AMENDMENT NO. 2 TO SCHEDULE 13D | 30 Jul 2020 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 18 Jun 2020 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 29 Apr 2020 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | AMENDMENT NO. 2 TO SCHEDULE 13D | 23 Mar 2020 | ||
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | SCHEDULE 13D | 07 Feb 2020 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Feb 2020 | 04 Feb 2020 | 001-39186 |
| 3/A | Open 3/A document | View SEC filing for 3/A | FORM 3/A SUBMISSION | 31 Jan 2020 | 30 Jan 2020 | 001-39186 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 30 Jan 2020 | 30 Jan 2020 | 001-39186 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 16 Jan 2020 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Jan 2020 | 09 Jan 2020 | 001-38670 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 13 Jan 2020 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SCHEDULE 13D/A (AMENDMENT NO. 1) | 23 Jan 2019 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 22 Jan 2019 | 18 Jan 2019 | 001-37449 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SCHEDULE 13D/A (AMENDMENT NO. 1) | 14 Nov 2018 | ||
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | SC 13D | 09 Oct 2018 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Oct 2018 | 28 Sep 2018 | 001-38670 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 25 Sep 2018 | 25 Sep 2018 | 001-38670 |
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | SC 13D | 05 Jul 2018 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 26 Jun 2018 | 25 Jun 2018 | 001-38535 |
| 3 | Open 3 document | View SEC filing for 3 | 3 | 20 Jun 2018 | 20 Jun 2018 | 001-38535 |
| SC 13D | Open SC 13D document | Open XBRL data | View SEC filing for SC 13D | SC 13D | 31 Jul 2017 | ||
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 28 Jul 2017 | 24 Jul 2017 | 001-37449 |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 24 Feb 2017 | 14 Feb 2017 | 001-37490 |
| D | Open D document | View SEC filing for D | 29 Oct 2015 | 021-250272 |
Frazier Life Sciences VIII, L.P. files with the SEC under CIK 0001655827. This page aggregates EDGAR filings and related ownership activity.